MORPHINE

MORPHINE was reported 121416 times

MORPHINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 102 0.4454
1 VAGINAL FLATULENCE 84 0.2772
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 141 0.2111
3 NEUROLOGIC NEGLECT SYNDROME 107 0.1924
4 LUPUS VULGARIS 216 0.1714
5 CAROTID ARTERY THROMBOSIS 107 0.1260
6 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 260 0.1254
7 DISLOCATION OF VERTEBRA 281 0.1231
8 SERONEGATIVE ARTHRITIS 140 0.1222
9 MATERNAL EXPOSURE DURING DELIVERY 113 0.1140
10 RETINITIS 197 0.1139
11 X-RAY ABNORMAL 196 0.1095
12 DEEP VEIN THROMBOSIS POSTOPERATIVE 214 0.1068
13 PORPHYRIA ACUTE 129 0.0899
14 ACCIDENTAL DEATH 162 0.0871
15 ADJUSTMENT DISORDER 111 0.0854
16 SWOLLEN JOINT COUNT INCREASED 245 0.0768
17 BRADYPNOEA 202 0.0748
18 CONTRAST MEDIA ALLERGY 134 0.0731
19 BONE EROSION 256 0.0723
20 FACET JOINT SYNDROME 235 0.0721
21 RESPIRATORY DEPRESSION 838 0.0683
22 PERSONALITY DISORDER 161 0.0614
23 FEMALE GENITAL TRACT FISTULA 104 0.0609
24 RHEUMATIC FEVER 268 0.0601
25 RHEUMATOID FACTOR POSITIVE 328 0.0567
26 C-REACTIVE PROTEIN ABNORMAL 362 0.0564
27 EXPOSURE VIA INGESTION 136 0.0539
28 OBLITERATIVE BRONCHIOLITIS 70 0.0533
29 PERIPHERAL VENOUS DISEASE 217 0.0531
30 DRUG TOLERANCE DECREASED 147 0.0523
31 SEDATION COMPLICATION 129 0.0505
32 RADICULOPATHY 127 0.0481
33 SUBSTANCE USE DISORDER 148 0.0464
34 TEMPERATURE REGULATION DISORDER 103 0.0462
35 RESPIRATORY RATE DECREASED 142 0.0452
36 MIOSIS 358 0.0446
37 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 303 0.0422
38 POISONING 514 0.0409
39 HYPERAESTHESIA 323 0.0393
40 DUODENAL ULCER PERFORATION 292 0.0392
41 ASPHYXIA 314 0.0384
42 PROCTITIS 106 0.0378
43 PSEUDOMONAL SEPSIS 66 0.0376
44 NEPHROGENIC ANAEMIA 168 0.0362
45 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 233 0.0358
46 HYPERPARATHYROIDISM SECONDARY 89 0.0355
47 BURSITIS 424 0.0349
48 RESPIRATORY ACIDOSIS 135 0.0343
49 DRUG ABUSE 2855 0.0343
50 BREAST CANCER STAGE III 221 0.0341
51 WOUND INFECTION 370 0.0338
52 CANCER PAIN 85 0.0332
53 HYPERCAPNIA 97 0.0322
54 BLOOD PRESSURE SYSTOLIC ABNORMAL 78 0.0315
55 EXOSTOSIS 285 0.0312
56 SPONDYLITIS 113 0.0310
57 METASTASES TO SPINE 102 0.0303
58 DRUG TOXICITY 404 0.0296
59 SEDATION 772 0.0294
60 APNOEA 228 0.0293
61 HYPOVENTILATION 95 0.0291
62 HYPERCHOLESTEROLAEMIA 278 0.0288
63 APLASTIC ANAEMIA 148 0.0283
64 GRIP STRENGTH DECREASED 247 0.0280
65 SUBSTANCE ABUSE 228 0.0280
66 AUTOIMMUNE DISORDER 273 0.0280
67 JOINT RANGE OF MOTION DECREASED 375 0.0279
68 BLOOD PRESSURE DIASTOLIC ABNORMAL 71 0.0279
69 MUSCLE INJURY 230 0.0277
70 LIP DRY 252 0.0277
71 SYNOVITIS 500 0.0277
72 DELIRIUM 958 0.0276
73 MUSCLE SPASTICITY 338 0.0275
74 DRUG USE DISORDER 231 0.0274
75 FOOT DEFORMITY 302 0.0272
76 HAND DEFORMITY 355 0.0270
77 HELICOBACTER INFECTION 277 0.0269
78 RESPIRATORY ARREST 739 0.0268
79 MULTIPLE DRUG OVERDOSE 129 0.0260
80 WALKING AID USER 170 0.0258
81 COLITIS MICROSCOPIC 121 0.0255
82 RHINALGIA 70 0.0254
83 SCIATICA 406 0.0254
84 SENSORY LOSS 205 0.0254
85 TOXICITY TO VARIOUS AGENTS 4289 0.0254
86 RED BLOOD CELL SEDIMENTATION RATE INCREASED 279 0.0252
87 REBOUND ACID HYPERSECRETION 76 0.0251
88 DRUG DIVERSION 153 0.0247
89 GANGRENE 149 0.0247
90 PLEURITIC PAIN 68 0.0246
91 FOETAL DEATH 127 0.0245
92 CLONUS 67 0.0245
93 PEMPHIGUS 305 0.0244
94 MATERNAL EXPOSURE TIMING UNSPECIFIED 91 0.0242
95 CARDIO-RESPIRATORY ARREST 1001 0.0239
96 SPINAL CORD COMPRESSION 93 0.0239
97 MYOCLONUS 283 0.0237
98 UNRESPONSIVE TO STIMULI 599 0.0232
99 LIVE BIRTH 194 0.0232
100 DRUG TOLERANCE 117 0.0231
101 ATELECTASIS 223 0.0231
102 JOINT DISLOCATION 243 0.0230
103 BRAIN OEDEMA 288 0.0228
104 LUPUS-LIKE SYNDROME 205 0.0226
105 MENTAL STATUS CHANGES 624 0.0224
106 STRIDOR 66 0.0224
107 PULMONARY FIBROSIS 423 0.0220
108 HYPERREFLEXIA 76 0.0218
109 ACIDOSIS 166 0.0217
110 SPINAL FUSION SURGERY 88 0.0217
111 FOLLICULITIS 227 0.0216
112 CHRONIC SINUSITIS 81 0.0216
113 ASPIRATION 236 0.0215
114 OBESITY 342 0.0214
115 BLOOD PRESSURE DIASTOLIC INCREASED 99 0.0214
116 DEPRESSED LEVEL OF CONSCIOUSNESS 838 0.0212
117 VASCULAR DEVICE INFECTION 96 0.0211
118 RENAL CYST 167 0.0210
119 ABDOMINAL TENDERNESS 104 0.0209
120 PULSELESS ELECTRICAL ACTIVITY 86 0.0206
121 PRESCRIBED OVERDOSE 398 0.0205
122 PULMONARY CONGESTION 271 0.0205
123 BONE LESION 74 0.0205
124 ACUTE PULMONARY OEDEMA 115 0.0205
125 GRANULOMA 70 0.0202
126 HYPOXIA 709 0.0201
127 COMPLETED SUICIDE 1670 0.0200
128 LEARNING DISABILITY 106 0.0199
129 PATHOLOGICAL FRACTURE 101 0.0199
130 BLOOD PRESSURE SYSTOLIC INCREASED 387 0.0198
131 FAILURE TO THRIVE 103 0.0198
132 THERAPEUTIC AGENT TOXICITY 66 0.0198
133 BRONCHOPNEUMONIA 67 0.0195
134 FOOD ALLERGY 151 0.0195
135 HEPATIC LESION 84 0.0194
136 HEMIPLEGIA 161 0.0193
137 HYPOVOLAEMIA 113 0.0193
138 PERICARDITIS 324 0.0193
139 BLOOD PRESSURE DIASTOLIC DECREASED 142 0.0192
140 LOWER LIMB FRACTURE 366 0.0190
141 WOUND 530 0.0189
142 MULTIPLE MYELOMA 88 0.0189
143 POISONING DELIBERATE 179 0.0189
144 DRUG SCREEN POSITIVE 147 0.0186
145 HEPATIC CIRRHOSIS 344 0.0183
146 SPINAL OSTEOARTHRITIS 160 0.0182
147 SPINAL COLUMN STENOSIS 86 0.0182
148 CREATININE RENAL CLEARANCE DECREASED 72 0.0180
149 SEROTONIN SYNDROME 344 0.0179
150 INTERVERTEBRAL DISC DISORDER 76 0.0178
151 MOTOR DYSFUNCTION 181 0.0177
152 INTERVERTEBRAL DISC DEGENERATION 164 0.0177
153 ARTERIAL OCCLUSIVE DISEASE 139 0.0177
154 OLIGURIA 109 0.0175
155 COMPRESSION FRACTURE 94 0.0175
156 FIBROMYALGIA 426 0.0175
157 SINUS TACHYCARDIA 248 0.0174
158 INADEQUATE ANALGESIA 148 0.0174
159 TERMINAL STATE 116 0.0173
160 INCOHERENT 112 0.0173
161 STAPHYLOCOCCAL BACTERAEMIA 75 0.0172
162 ILEUS PARALYTIC 77 0.0172
163 GLOSSODYNIA 385 0.0172
164 DECUBITUS ULCER 140 0.0172
165 FEBRILE NEUTROPENIA 1129 0.0170
166 ACUTE RESPIRATORY FAILURE 327 0.0170
167 CARDIOMEGALY 208 0.0169
168 PERIPHERAL ISCHAEMIA 69 0.0169
169 COMA 802 0.0168
170 ENCEPHALOPATHY 412 0.0168
171 METASTASES TO BONE 274 0.0167
172 RESPIRATORY DISTRESS 459 0.0166
173 WHITE BLOOD CELL COUNT ABNORMAL 106 0.0166
174 BREAST CANCER STAGE II 138 0.0166
175 RESPIRATORY RATE INCREASED 147 0.0165
176 MULTI-ORGAN FAILURE 286 0.0165
177 HEPARIN-INDUCED THROMBOCYTOPENIA 81 0.0164
178 MALNUTRITION 183 0.0163
179 CONTRAINDICATED PRODUCT ADMINISTERED 493 0.0163
180 IMPAIRED HEALING 534 0.0162
181 BODY TEMPERATURE DECREASED 160 0.0162
182 CACHEXIA 83 0.0161
183 RESPIRATORY FAILURE 1176 0.0161
184 PROTHROMBIN TIME PROLONGED 96 0.0160
185 SUSPECTED SUICIDE 75 0.0160
186 MUCOSAL INFLAMMATION 418 0.0159
187 METASTASES TO LYMPH NODES 107 0.0158
188 ARTERIOSCLEROSIS CORONARY ARTERY 105 0.0158
189 IMMUNODEFICIENCY 236 0.0158
190 CARDIAC ARREST 1304 0.0158
191 ILEUS 196 0.0158
192 PULMONARY OEDEMA 705 0.0157
193 LEFT VENTRICULAR HYPERTROPHY 67 0.0156
194 BRAIN INJURY 154 0.0153
195 RALES 89 0.0153
196 EMPHYSEMA 153 0.0152
197 OXYGEN SATURATION DECREASED 852 0.0151
198 FLANK PAIN 142 0.0151
199 ACCIDENTAL OVERDOSE 553 0.0151
200 ORAL CANDIDIASIS 197 0.0149
201 POST PROCEDURAL COMPLICATION 286 0.0149
202 AFFECT LABILITY 143 0.0148
203 LEUKOCYTOSIS 268 0.0148
204 OSTEOARTHRITIS 625 0.0147
205 METASTASIS 105 0.0147
206 END STAGE RENAL DISEASE 268 0.0147
207 METASTASES TO LUNG 169 0.0146
208 SMALL INTESTINAL OBSTRUCTION 180 0.0146
209 HYPOTHERMIA 147 0.0145
210 LUNG INFILTRATION 128 0.0145
211 ABDOMINAL HERNIA 66 0.0145
212 DRUG WITHDRAWAL SYNDROME NEONATAL 214 0.0144
213 INFUSION RELATED REACTION 957 0.0144
214 FAECALOMA 79 0.0144
215 IRRITABLE BOWEL SYNDROME 309 0.0144
216 BLOOD MAGNESIUM DECREASED 124 0.0144
217 HIP ARTHROPLASTY 220 0.0144
218 LIVER INJURY 352 0.0143
219 CLOSTRIDIUM DIFFICILE COLITIS 152 0.0143
220 PULMONARY HAEMORRHAGE 112 0.0143
221 SLEEP APNOEA SYNDROME 273 0.0143
222 BLOOD PRESSURE SYSTOLIC DECREASED 65 0.0143
223 C-REACTIVE PROTEIN INCREASED 519 0.0143
224 BODY TEMPERATURE INCREASED 291 0.0142
225 AFFECTIVE DISORDER 112 0.0142
226 TRICUSPID VALVE INCOMPETENCE 113 0.0142
227 PNEUMONIA ASPIRATION 355 0.0142
228 NECROSIS 79 0.0142
229 STAPHYLOCOCCAL SEPSIS 70 0.0142
230 RENAL TUBULAR NECROSIS 138 0.0141
231 KLEBSIELLA INFECTION 71 0.0140
232 LARGE INTESTINE PERFORATION 97 0.0140
233 HYDRONEPHROSIS 104 0.0139
234 URINE OUTPUT DECREASED 121 0.0138
235 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 70 0.0138
236 HEMIPARESIS 234 0.0138
237 NO THERAPEUTIC RESPONSE 167 0.0137
238 CONFUSIONAL STATE 2212 0.0137
239 PROCTALGIA 88 0.0137
240 ROAD TRAFFIC ACCIDENT 571 0.0136
241 ARTERIOSCLEROSIS 128 0.0136
242 SPINAL PAIN 159 0.0136
243 GINGIVITIS 73 0.0135
244 GENERAL PHYSICAL HEALTH DETERIORATION 1560 0.0135
245 COORDINATION ABNORMAL 188 0.0135
246 PLEURAL EFFUSION 816 0.0134
247 URINARY RETENTION 445 0.0133
248 SPUTUM DISCOLOURED 126 0.0133
249 INTESTINAL ISCHAEMIA 73 0.0132
250 VENTRICULAR FIBRILLATION 147 0.0132
251 CHOLESTASIS 254 0.0132
252 OEDEMA 717 0.0132
253 OBSTRUCTIVE AIRWAYS DISORDER 147 0.0132
254 ANGIOPATHY 74 0.0132
255 NEUTROPHIL COUNT INCREASED 135 0.0132
256 VARICOSE VEIN 68 0.0132
257 MUSCULOSKELETAL CHEST PAIN 203 0.0131
258 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 224 0.0131
259 UPPER RESPIRATORY TRACT INFECTION 601 0.0130
260 DEVELOPMENTAL DELAY 117 0.0130
261 HYPERTHERMIA 99 0.0130
262 MUSCULOSKELETAL PAIN 676 0.0129
263 INJURY 906 0.0129
264 DRUG INTOLERANCE 1244 0.0129
265 INTENTIONAL DRUG MISUSE 269 0.0129
266 HAEMODYNAMIC INSTABILITY 98 0.0128
267 HYPOALBUMINAEMIA 100 0.0128
268 CANDIDA INFECTION 217 0.0128
269 LUNG DISORDER 629 0.0128
270 EATING DISORDER 273 0.0128
271 BACTERAEMIA 152 0.0128
272 CYANOSIS 201 0.0128
273 FREQUENT BOWEL MOVEMENTS 345 0.0128
274 BLOOD ALBUMIN DECREASED 101 0.0127
275 METASTASES TO CENTRAL NERVOUS SYSTEM 164 0.0127
276 CELLULITIS 640 0.0127
277 CHOLECYSTITIS CHRONIC 85 0.0127
278 RHEUMATOID ARTHRITIS 1440 0.0127
279 NEURALGIA 308 0.0127
280 INGUINAL HERNIA 77 0.0126
281 RESPIRATORY DISORDER 378 0.0126
282 BLOOD CALCIUM DECREASED 142 0.0126
283 LOWER RESPIRATORY TRACT INFECTION 574 0.0126
284 SPINAL DISORDER 119 0.0126
285 ACUTE RESPIRATORY DISTRESS SYNDROME 222 0.0125
286 VENTRICULAR TACHYCARDIA 207 0.0125
287 DECREASED IMMUNE RESPONSIVENESS 123 0.0125
288 NERVE INJURY 139 0.0125
289 RENAL FAILURE ACUTE 530 0.0125
290 SPINAL COMPRESSION FRACTURE 103 0.0124
291 OSTEOPOROSIS 512 0.0124
292 HALLUCINATION, VISUAL 262 0.0124
293 TENDERNESS 129 0.0124
294 MULTIPLE ORGAN DYSFUNCTION SYNDROME 349 0.0123
295 PNEUMOTHORAX 195 0.0123
296 TYPE 2 DIABETES MELLITUS 413 0.0123
297 FEELING OF BODY TEMPERATURE CHANGE 71 0.0121
298 MOBILITY DECREASED 869 0.0121
299 DYSARTHRIA 454 0.0120
300 PRESCRIBED UNDERDOSE 240 0.0120
301 HEPATOMEGALY 118 0.0120
302 COAGULOPATHY 200 0.0120
303 TACHYPNOEA 163 0.0120
304 KNEE ARTHROPLASTY 252 0.0120
305 DRUG INTERACTION 1891 0.0119
306 TACHYCARDIA 1058 0.0119
307 DRUG LEVEL INCREASED 197 0.0119
308 OESOPHAGITIS 130 0.0119
309 ARTHROPATHY 661 0.0119
310 COLITIS 449 0.0118
311 SEPSIS 1316 0.0118
312 NIGHT SWEATS 380 0.0118
313 SINUS CONGESTION 159 0.0118
314 DENTAL CARIES 130 0.0117
315 ENTERITIS 75 0.0117
316 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 91 0.0117
317 LYMPHOEDEMA 81 0.0117
318 BLOOD PRESSURE FLUCTUATION 280 0.0117
319 MITRAL VALVE INCOMPETENCE 132 0.0117
320 RENAL INJURY 346 0.0116
321 BACK DISORDER 189 0.0116
322 HYPOTENSION 2330 0.0116
323 HYPOKALAEMIA 536 0.0116
324 OSTEOMYELITIS 210 0.0116
325 RENAL FAILURE CHRONIC 89 0.0116
326 PULMONARY HYPERTENSION 241 0.0116
327 DRUG ABUSER 71 0.0115
328 MYDRIASIS 148 0.0115
329 JOINT STIFFNESS 302 0.0115
330 REFUSAL OF TREATMENT BY PATIENT 75 0.0115
331 RIB FRACTURE 236 0.0115
332 BRADYCARDIA 607 0.0114
333 SPLENOMEGALY 134 0.0114
334 BLOOD ALKALINE PHOSPHATASE INCREASED 284 0.0114
335 HYPERKALAEMIA 400 0.0114
336 TROPONIN INCREASED 86 0.0113
337 INTERVERTEBRAL DISC PROTRUSION 247 0.0113
338 WHEEZING 670 0.0113
339 HEPATOCELLULAR INJURY 160 0.0113
340 CARDIOGENIC SHOCK 161 0.0112
341 WITHDRAWAL SYNDROME 471 0.0112
342 PULMONARY MASS 167 0.0112
343 METASTASES TO LIVER 197 0.0112
344 DRUG WITHDRAWAL SYNDROME 982 0.0112
345 ORAL DISORDER 82 0.0112
346 ACUTE KIDNEY INJURY 1710 0.0112
347 SINUS BRADYCARDIA 108 0.0112
348 WHITE BLOOD CELL COUNT INCREASED 425 0.0111
349 TOXIC EPIDERMAL NECROLYSIS 168 0.0111
350 MENISCUS INJURY 68 0.0110
351 ODYNOPHAGIA 66 0.0110
352 RECTAL HAEMORRHAGE 473 0.0110
353 EAR PAIN 214 0.0110
354 METABOLIC ACIDOSIS 352 0.0110
355 OVERDOSE 2372 0.0110
356 ELECTROCARDIOGRAM ABNORMAL 86 0.0109
357 LETHARGY 628 0.0109
358 HEPATIC STEATOSIS 203 0.0109
359 RENAL FAILURE 1447 0.0109
360 PSORIATIC ARTHROPATHY 442 0.0109
361 CHRONIC KIDNEY DISEASE 827 0.0109
362 HYPERHIDROSIS 1401 0.0109
363 BRADYPHRENIA 71 0.0109
364 NEUROTOXICITY 190 0.0108
365 ABDOMINAL PAIN 2520 0.0108
366 STOMATITIS 656 0.0108
367 BONE DISORDER 197 0.0108
368 TUMOUR LYSIS SYNDROME 95 0.0108
369 HYPOPHAGIA 276 0.0108
370 HAEMATOCRIT DECREASED 214 0.0108
371 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 103 0.0108
372 DISORIENTATION 427 0.0108
373 VAGINAL DISCHARGE 109 0.0108
374 INFLAMMATION 554 0.0107
375 PSEUDOMONAS INFECTION 92 0.0107
376 MALIGNANT NEOPLASM PROGRESSION 1098 0.0107
377 SEPTIC SHOCK 466 0.0107
378 SOMNOLENCE 2156 0.0107
379 TORSADE DE POINTES 84 0.0107
380 ARTHRITIS 842 0.0107
381 CONSTIPATION 2334 0.0107
382 HYPOPHOSPHATAEMIA 79 0.0107
383 CYSTITIS 340 0.0107
384 HIATUS HERNIA 138 0.0106
385 NEUTROPENIC SEPSIS 76 0.0106
386 BLOOD BILIRUBIN INCREASED 287 0.0106
387 INTESTINAL OBSTRUCTION 400 0.0106
388 NIGHTMARE 365 0.0105
389 ASCITES 310 0.0105
390 THROMBOCYTOPENIA 1170 0.0105
391 NEOPLASM PROGRESSION 363 0.0104
392 APPETITE DISORDER 69 0.0104
393 OEDEMA PERIPHERAL 1268 0.0104
394 HEPATIC ENZYME INCREASED 705 0.0103
395 ABSCESS 165 0.0103
396 SUPRAVENTRICULAR TACHYCARDIA 99 0.0103
397 INTESTINAL PERFORATION 116 0.0103
398 ANKYLOSING SPONDYLITIS 136 0.0103
399 EAR INFECTION 274 0.0103
400 AMNESIA 666 0.0102
401 ANHEDONIA 269 0.0102
402 PANCREATITIS ACUTE 230 0.0102
403 DISSEMINATED INTRAVASCULAR COAGULATION 144 0.0102
404 SHOCK HAEMORRHAGIC 83 0.0102
405 SYSTEMIC LUPUS ERYTHEMATOSUS 361 0.0102
406 LIVER FUNCTION TEST INCREASED 218 0.0101
407 BLOOD CALCIUM INCREASED 89 0.0101
408 GROIN PAIN 89 0.0101
409 HYPERLIPIDAEMIA 121 0.0101
410 SKIN HAEMORRHAGE 150 0.0101
411 CONCUSSION 78 0.0101
412 ELECTROLYTE IMBALANCE 117 0.0101
413 BOWEL MOVEMENT IRREGULARITY 77 0.0100
414 BLISTER 563 0.0100
415 BACK INJURY 109 0.0100
416 HYPOTONIA 100 0.0100
417 EXPOSURE DURING PREGNANCY 622 0.0100
418 LEFT VENTRICULAR DYSFUNCTION 67 0.0100
419 POST-TRAUMATIC STRESS DISORDER 67 0.0100
420 DIVERTICULITIS 277 0.0100
421 HEPATIC FAILURE 301 0.0100
422 ANAPHYLACTIC REACTION 551 0.0100
423 COLITIS ISCHAEMIC 67 0.0099
424 GAMMA-GLUTAMYLTRANSFERASE INCREASED 220 0.0099
425 DISCOMFORT 605 0.0099
426 GAIT INABILITY 331 0.0099
427 RIGHT VENTRICULAR FAILURE 69 0.0098
428 PAIN 6048 0.0098
429 SKIN PLAQUE 83 0.0098
430 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 167 0.0098
431 HOSPICE CARE 97 0.0098
432 RESPIRATORY TRACT CONGESTION 156 0.0098
433 ANGINA PECTORIS 280 0.0098
434 CHOLELITHIASIS 320 0.0097
435 BEDRIDDEN 128 0.0097
436 PREMATURE DELIVERY 155 0.0097
437 RESTLESSNESS 356 0.0097
438 VENTRICULAR EXTRASYSTOLES 101 0.0097
439 LIVER DISORDER 431 0.0097
440 HALLUCINATION 732 0.0097
441 DIVERTICULUM 69 0.0097
442 TOOTH FRACTURE 107 0.0097
443 PULMONARY EMBOLISM 920 0.0097
444 PNEUMONIA 3128 0.0097
445 DEVICE RELATED INFECTION 148 0.0096
446 MUSCULOSKELETAL STIFFNESS 841 0.0096
447 LUNG INFECTION 149 0.0096
448 COELIAC DISEASE 94 0.0096
449 ANAL INCONTINENCE 86 0.0096
450 JOINT SWELLING 1154 0.0096
451 WEIGHT FLUCTUATION 100 0.0095
452 BLOOD UREA INCREASED 160 0.0095
453 VOMITING 4491 0.0095
454 NEPHROLITHIASIS 437 0.0095
455 DYSPHAGIA 903 0.0095
456 BREAST CANCER METASTATIC 102 0.0095
457 ADRENAL INSUFFICIENCY 115 0.0095
458 APHASIA 286 0.0095
459 BONE PAIN 554 0.0094
460 DEHYDRATION 1258 0.0094
461 LIGAMENT SPRAIN 93 0.0094
462 UPPER GASTROINTESTINAL HAEMORRHAGE 158 0.0094
463 BRONCHOSPASM 134 0.0094
464 SKIN REACTION 132 0.0094
465 RASH MACULO-PAPULAR 208 0.0093
466 BLOOD POTASSIUM DECREASED 281 0.0093
467 PANCYTOPENIA 522 0.0093
468 HYPOMAGNESAEMIA 130 0.0093
469 BACK PAIN 2167 0.0093
470 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 486 0.0093
471 MULTIPLE ALLERGIES 73 0.0093
472 ECONOMIC PROBLEM 141 0.0093
473 GENERALISED OEDEMA 115 0.0093
474 SINUS DISORDER 184 0.0093
475 ALTERED STATE OF CONSCIOUSNESS 201 0.0093
476 FLUID OVERLOAD 135 0.0093
477 PROCEDURAL COMPLICATION 71 0.0093
478 CLOSTRIDIUM DIFFICILE INFECTION 202 0.0092
479 PANCREATITIS 489 0.0092
480 HYPERCALCAEMIA 114 0.0092
481 PYELONEPHRITIS 80 0.0092
482 BLOOD CHOLESTEROL INCREASED 430 0.0092
483 HALLUCINATION, AUDITORY 146 0.0092
484 GALLBLADDER DISORDER 164 0.0092
485 LOW BIRTH WEIGHT BABY 73 0.0092
486 SKIN ULCER 237 0.0092
487 GASTRIC ULCER 173 0.0091
488 DRUG DEPENDENCE 1460 0.0091
489 MOUTH ULCERATION 191 0.0091
490 RHINITIS 73 0.0090
491 ULCER 143 0.0090
492 AGITATION 660 0.0090
493 HYPERBILIRUBINAEMIA 93 0.0090
494 INTENTIONAL PRODUCT MISUSE 785 0.0090
495 DISABILITY 177 0.0089
496 MUSCLE RIGIDITY 107 0.0089
497 CHOLECYSTECTOMY 102 0.0089
498 NERVE COMPRESSION 82 0.0089
499 SICKLE CELL ANAEMIA WITH CRISIS 140 0.0089
500 STAPHYLOCOCCAL INFECTION 293 0.0089
501 GRAND MAL CONVULSION 82 0.0089
502 CIRCULATORY COLLAPSE 151 0.0089
503 ELECTROCARDIOGRAM QT PROLONGED 318 0.0088
504 NECK PAIN 494 0.0088
505 LIVER FUNCTION TEST ABNORMAL 257 0.0088
506 SPINAL FRACTURE 177 0.0088
507 SWELLING 825 0.0088
508 MASS 123 0.0088
509 IMPAIRED DRIVING ABILITY 100 0.0088
510 QUALITY OF LIFE DECREASED 118 0.0088
511 DEEP VEIN THROMBOSIS 571 0.0088
512 CYTOKINE RELEASE SYNDROME 176 0.0088
513 PYREXIA 3035 0.0088
514 HYPOTHYROIDISM 280 0.0088
515 MUSCULAR WEAKNESS 995 0.0087
516 PALLOR 238 0.0087
517 PARALYSIS 125 0.0087
518 WEIGHT DECREASED 2436 0.0087
519 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 419 0.0087
520 ACUTE HEPATIC FAILURE 119 0.0087
521 OSTEOPENIA 132 0.0087
522 FEEDING DISORDER 176 0.0087
523 FEAR 233 0.0087
524 CHOLECYSTITIS 103 0.0086
525 TOOTH ABSCESS 88 0.0086
526 APHTHOUS ULCER 67 0.0086
527 PREMATURE BABY 259 0.0086
528 SLEEP DISORDER 607 0.0086
529 LYMPHOCYTE COUNT DECREASED 152 0.0086
530 TRANSFUSION 90 0.0086
531 RESTLESS LEGS SYNDROME 156 0.0086
532 ROTATOR CUFF SYNDROME 110 0.0086
533 PNEUMONITIS 233 0.0085
534 GINGIVAL PAIN 68 0.0085
535 HEART RATE DECREASED 300 0.0085
536 HYPONATRAEMIA 481 0.0085
537 MYOSITIS 76 0.0085
538 TREATMENT FAILURE 700 0.0084
539 CONTUSION 813 0.0084
540 HAEMATEMESIS 214 0.0084
541 ORTHOSTATIC HYPOTENSION 147 0.0084
542 INCONTINENCE 89 0.0084
543 SECOND PRIMARY MALIGNANCY 70 0.0084
544 THERAPY NON-RESPONDER 378 0.0084
545 DEVICE FAILURE 128 0.0084
546 FACIAL PAIN 75 0.0084
547 SNEEZING 188 0.0084
548 ANOREXIA 108 0.0084
549 ACCIDENT 100 0.0084
550 SKIN LACERATION 91 0.0084
551 TOOTH DISORDER 186 0.0084
552 DISEASE PROGRESSION 986 0.0083
553 CHEST PAIN 1543 0.0083
554 PARAESTHESIA ORAL 120 0.0083
555 BRONCHITIS 613 0.0083
556 ATRIAL FLUTTER 66 0.0083
557 POST PROCEDURAL INFECTION 67 0.0082
558 THERAPEUTIC PRODUCT EFFECT DECREASED 368 0.0082
559 HAEMOPTYSIS 229 0.0082
560 MUSCLE STRAIN 71 0.0082
561 HYPOKINESIA 119 0.0082
562 HYPERTENSION 1732 0.0082
563 INTERNATIONAL NORMALISED RATIO INCREASED 233 0.0082
564 ANAEMIA 1558 0.0082
565 GLAUCOMA 157 0.0081
566 INFECTION 1177 0.0081
567 BLOOD POTASSIUM INCREASED 132 0.0081
568 DYSURIA 298 0.0081
569 DYSPEPSIA 796 0.0081
570 ORAL PAIN 181 0.0081
571 LOCAL SWELLING 141 0.0081
572 LOSS OF CONSCIOUSNESS 1033 0.0081
573 PURPURA 71 0.0080
574 ANXIETY 2283 0.0080
575 DYSKINESIA 326 0.0080
576 POST PROCEDURAL HAEMORRHAGE 93 0.0080
577 HAEMOGLOBIN DECREASED 818 0.0080
578 HERNIA 154 0.0080
579 SHOCK 183 0.0079
580 BLADDER DISORDER 79 0.0079
581 THYROID DISORDER 122 0.0079
582 FOOT FRACTURE 150 0.0079
583 MEDICATION ERROR 439 0.0079
584 TOOTH INFECTION 104 0.0079
585 COLITIS ULCERATIVE 352 0.0079
586 DECREASED APPETITE 1829 0.0079
587 BLOOD PRESSURE DECREASED 522 0.0078
588 CARPAL TUNNEL SYNDROME 110 0.0078
589 POLYNEUROPATHY 94 0.0078
590 ACUTE MYOCARDIAL INFARCTION 231 0.0078
591 SINUSITIS 802 0.0078
592 LOCALISED INFECTION 189 0.0078
593 AGGRESSION 391 0.0078
594 IMPAIRED GASTRIC EMPTYING 106 0.0078
595 FACE OEDEMA 131 0.0078
596 HAEMATOMA 201 0.0078
597 SUBDURAL HAEMATOMA 111 0.0077
598 SUDDEN DEATH 82 0.0077
599 LYMPHADENOPATHY 274 0.0077
600 RETCHING 165 0.0077
601 MATERNAL EXPOSURE DURING PREGNANCY 687 0.0077
602 ANURIA 66 0.0077
603 IMMUNE SYSTEM DISORDER 101 0.0077
604 MYOCARDIAL ISCHAEMIA 87 0.0076
605 HYPOAESTHESIA 1143 0.0076
606 DRY MOUTH 619 0.0076
607 RHABDOMYOLYSIS 318 0.0076
608 GASTROINTESTINAL DISORDER 683 0.0076
609 DYSSTASIA 222 0.0076
610 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 78 0.0076
611 UROSEPSIS 70 0.0076
612 JOINT INJURY 162 0.0076
613 FEELING HOT 464 0.0076
614 BLOOD CREATININE INCREASED 493 0.0075
615 PRODUCTIVE COUGH 360 0.0075
616 ALANINE AMINOTRANSFERASE INCREASED 463 0.0075
617 HYPERSOMNIA 216 0.0075
618 GAIT DISTURBANCE 1442 0.0075
619 ASPARTATE AMINOTRANSFERASE INCREASED 400 0.0075
620 BLOOD PRESSURE INCREASED 1150 0.0075
621 HEPATIC ENCEPHALOPATHY 70 0.0075
622 PERIPHERAL COLDNESS 103 0.0075
623 URINARY INCONTINENCE 222 0.0075
624 MIGRAINE 715 0.0075
625 PAIN IN EXTREMITY 2200 0.0075
626 LACERATION 70 0.0074
627 PLATELET COUNT INCREASED 97 0.0074
628 BLOOD SODIUM DECREASED 140 0.0074
629 EUPHORIC MOOD 76 0.0074
630 MUSCLE TWITCHING 171 0.0074
631 HYPOCALCAEMIA 140 0.0074
632 HERPES ZOSTER 424 0.0074
633 GASTROOESOPHAGEAL REFLUX DISEASE 594 0.0074
634 COLD SWEAT 130 0.0074
635 SARS-COV-2 TEST POSITIVE 97 0.0073
636 PERIPHERAL SWELLING 1129 0.0073
637 PROCEDURAL PAIN 203 0.0073
638 CHILLS 857 0.0073
639 NAUSEA 5772 0.0073
640 ILL-DEFINED DISORDER 443 0.0073
641 TRANSAMINASES INCREASED 162 0.0073
642 FALL 2418 0.0073
643 BLOOD TEST ABNORMAL 102 0.0073
644 MEMORY IMPAIRMENT 996 0.0072
645 SPEECH DISORDER 379 0.0072
646 HEPATOTOXICITY 161 0.0072
647 HAEMORRHOIDS 141 0.0072
648 SKIN LESION 197 0.0072
649 POOR VENOUS ACCESS 74 0.0071
650 PLASMA CELL MYELOMA 279 0.0071
651 PERICARDIAL EFFUSION 165 0.0071
652 ASTHMA 806 0.0071
653 KIDNEY INFECTION 139 0.0071
654 PAIN IN JAW 200 0.0071
655 LEUKOPENIA 353 0.0071
656 CARDIOMYOPATHY 104 0.0070
657 OSTEONECROSIS OF JAW 174 0.0070
658 HIP FRACTURE 226 0.0070
659 SECRETION DISCHARGE 88 0.0070
660 FLUID RETENTION 357 0.0070
661 NERVOUS SYSTEM DISORDER 219 0.0070
662 TOOTH EXTRACTION 87 0.0070
663 URINARY TRACT INFECTION 1191 0.0070
664 HEPATIC CYTOLYSIS 89 0.0070
665 INTENTIONAL PRODUCT USE ISSUE 610 0.0070
666 HAEMATURIA 238 0.0069
667 RHINORRHOEA 446 0.0069
668 ASTHENIA 2594 0.0069
669 BLOOD CREATINE PHOSPHOKINASE INCREASED 198 0.0069
670 DRUG LEVEL DECREASED 70 0.0069
671 SKIN INFECTION 77 0.0069
672 DECREASED ACTIVITY 74 0.0069
673 BLOOD URINE PRESENT 130 0.0068
674 NEUROPATHY PERIPHERAL 651 0.0068
675 GASTRITIS 180 0.0068
676 EMOTIONAL DISTRESS 828 0.0068
677 EJECTION FRACTION DECREASED 106 0.0068
678 ABDOMINAL PAIN UPPER 1403 0.0068
679 DIZZINESS POSTURAL 66 0.0068
680 TOOTHACHE 123 0.0068
681 DELUSION 105 0.0068
682 MOVEMENT DISORDER 217 0.0068
683 HYPERGLYCAEMIA 246 0.0067
684 PLATELET COUNT DECREASED 716 0.0067
685 RASH ERYTHEMATOUS 321 0.0067
686 PREGNANCY 134 0.0067
687 COGNITIVE DISORDER 312 0.0067
688 FISTULA 75 0.0067
689 ANAPHYLACTIC SHOCK 172 0.0067
690 TUBULOINTERSTITIAL NEPHRITIS 125 0.0067
691 SCAB 76 0.0067
692 SCAR 114 0.0067
693 STEVENS-JOHNSON SYNDROME 147 0.0066
694 MYOCARDITIS 75 0.0065
695 MIDDLE INSOMNIA 122 0.0065
696 CAESAREAN SECTION 76 0.0065
697 DERMATITIS ALLERGIC 82 0.0065
698 FEELING COLD 181 0.0065
699 DEPRESSION 1469 0.0064
700 GASTROINTESTINAL PAIN 71 0.0064
701 BODY HEIGHT DECREASED 69 0.0064
702 SCRATCH 68 0.0064
703 ATRIAL FIBRILLATION 627 0.0064
704 GASTRIC HAEMORRHAGE 74 0.0064
705 DYSPNOEA 3640 0.0064
706 CHROMATURIA 145 0.0064
707 HAEMATOCHEZIA 354 0.0064
708 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 456 0.0064
709 INFLUENZA 714 0.0064
710 INSOMNIA 1705 0.0064
711 ABDOMINAL PAIN LOWER 161 0.0064
712 PSYCHOTIC DISORDER 188 0.0064
713 MACULAR DEGENERATION 76 0.0064
714 NEUTROPHIL COUNT DECREASED 259 0.0063
715 RENAL IMPAIRMENT 533 0.0063
716 PETECHIAE 66 0.0063
717 PARANOIA 109 0.0063
718 GASTROENTERITIS 92 0.0063
719 ABDOMINAL DISTENSION 656 0.0063
720 DEVICE OCCLUSION 88 0.0062
721 MENTAL DISORDER 272 0.0062
722 BLOOD IRON DECREASED 74 0.0062
723 CATARACT 371 0.0062
724 HYPOGLYCAEMIA 302 0.0062
725 JAUNDICE 167 0.0062
726 CYST 77 0.0062
727 LABORATORY TEST ABNORMAL 183 0.0062
728 RED BLOOD CELL COUNT DECREASED 177 0.0062
729 THROMBOSIS 498 0.0062
730 DYSPNOEA EXERTIONAL 233 0.0062
731 EPISTAXIS 462 0.0062
732 HEPATITIS 158 0.0062
733 MUSCLE SPASMS 1131 0.0062
734 ABNORMAL BEHAVIOUR 244 0.0062
735 LACTIC ACIDOSIS 199 0.0061
736 MALAISE 2693 0.0061
737 POOR QUALITY SLEEP 132 0.0061
738 NODULE 80 0.0061
739 NEUTROPENIA 828 0.0061
740 PERITONITIS 126 0.0061
741 HYPERSENSITIVITY 1129 0.0061
742 UPPER LIMB FRACTURE 121 0.0061
743 FOETAL EXPOSURE DURING PREGNANCY 493 0.0061
744 BACTERIAL INFECTION 113 0.0061
745 CONDITION AGGRAVATED 1835 0.0060
746 HAEMORRHAGE INTRACRANIAL 90 0.0060
747 BALANCE DISORDER 520 0.0060
748 CORONARY ARTERY DISEASE 182 0.0060
749 ACTIVITIES OF DAILY LIVING IMPAIRED 119 0.0060
750 WRIST FRACTURE 72 0.0060
751 PRESYNCOPE 146 0.0060
752 CONVULSION 343 0.0060
753 BLOOD PRESSURE ABNORMAL 119 0.0060
754 TOOTH LOSS 124 0.0060
755 NASOPHARYNGITIS 1101 0.0060
756 PARAESTHESIA 939 0.0060
757 ARTHRALGIA 2478 0.0060
758 VIRAL INFECTION 198 0.0059
759 BLOOD LACTATE DEHYDROGENASE INCREASED 94 0.0059
760 CARDIAC FAILURE 474 0.0059
761 THINKING ABNORMAL 110 0.0059
762 NEUROLEPTIC MALIGNANT SYNDROME 70 0.0059
763 CEREBRAL HAEMORRHAGE 211 0.0059
764 GASTROINTESTINAL HAEMORRHAGE 492 0.0059
765 PHARYNGITIS 73 0.0059
766 PROSTATIC SPECIFIC ANTIGEN INCREASED 81 0.0059
767 DIARRHOEA 3788 0.0059
768 MUSCULOSKELETAL DISCOMFORT 101 0.0059
769 WEIGHT INCREASED 1311 0.0058
770 MUSCULOSKELETAL DISORDER 111 0.0058
771 CHEST DISCOMFORT 596 0.0058
772 HEART RATE INCREASED 576 0.0058
773 TREMOR 962 0.0058
774 SCHIZOPHRENIA 70 0.0058
775 ABDOMINAL DISCOMFORT 965 0.0057
776 ANKLE FRACTURE 89 0.0057
777 PSYCHOMOTOR HYPERACTIVITY 95 0.0057
778 HEART RATE IRREGULAR 129 0.0057
779 EOSINOPHILIA 99 0.0056
780 HEAD INJURY 178 0.0056
781 DIPLOPIA 146 0.0056
782 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 131 0.0056
783 PSORIASIS 733 0.0056
784 BONE MARROW FAILURE 114 0.0056
785 MUSCLE ATROPHY 71 0.0056
786 NOCTURIA 68 0.0056
787 URTICARIA 938 0.0056
788 LIMB INJURY 152 0.0056
789 FATIGUE 4339 0.0056
790 MUSCLE TIGHTNESS 90 0.0056
791 ABASIA 137 0.0055
792 ACUTE MYELOID LEUKAEMIA 86 0.0055
793 OROPHARYNGEAL PAIN 507 0.0055
794 UNEVALUABLE EVENT 412 0.0054
795 SPINAL OPERATION 67 0.0054
796 WHITE BLOOD CELL COUNT DECREASED 588 0.0054
797 COUGH 1520 0.0054
798 DEPENDENCE 297 0.0054
799 FAECES DISCOLOURED 117 0.0054
800 SYNCOPE 538 0.0054
801 GASTROENTERITIS VIRAL 97 0.0054
802 GOUT 96 0.0053
803 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 292 0.0053
804 RESPIRATORY TRACT INFECTION 138 0.0053
805 PRODUCT USE ISSUE 993 0.0053
806 FLATULENCE 297 0.0052
807 APHONIA 73 0.0052
808 PELVIC PAIN 95 0.0052
809 DEATH 4499 0.0052
810 GINGIVAL BLEEDING 71 0.0052
811 BURNING SENSATION 364 0.0052
812 DEMENTIA 144 0.0051
813 CARDIAC FAILURE CONGESTIVE 413 0.0051
814 INFLUENZA LIKE ILLNESS 423 0.0051
815 GENERALISED TONIC-CLONIC SEIZURE 85 0.0051
816 DISTURBANCE IN ATTENTION 277 0.0051
817 FUNGAL INFECTION 171 0.0051
818 ORAL HERPES 100 0.0051
819 MULTIPLE FRACTURES 84 0.0051
820 MELAENA 112 0.0051
821 HEADACHE 3178 0.0051
822 ARRHYTHMIA 240 0.0051
823 WRONG TECHNIQUE IN DRUG USAGE PROCESS 184 0.0051
824 CRYING 183 0.0050
825 TASTE DISORDER 102 0.0050
826 DIABETES MELLITUS 383 0.0050
827 CHOKING 98 0.0050
828 RENAL DISORDER 234 0.0050
829 ANGIOEDEMA 222 0.0050
830 DRUG PRESCRIBING ERROR 96 0.0050
831 PANIC ATTACK 182 0.0050
832 EXTRAPYRAMIDAL DISORDER 124 0.0050
833 THERAPEUTIC RESPONSE DECREASED 302 0.0050
834 NERVOUSNESS 260 0.0050
835 SKIN DISORDER 165 0.0049
836 LIMB DISCOMFORT 153 0.0049
837 INTENTIONAL OVERDOSE 314 0.0049
838 ORAL DISCOMFORT 68 0.0049
839 NEOPLASM MALIGNANT 326 0.0049
840 SKIN DISCOLOURATION 224 0.0049
841 EPILEPSY 149 0.0049
842 SEIZURE 560 0.0048
843 LYMPHOPENIA 68 0.0048
844 DRUG-INDUCED LIVER INJURY 150 0.0048
845 GASTRIC DISORDER 164 0.0048
846 OFF LABEL USE 4156 0.0047
847 THERAPY PARTIAL RESPONDER 74 0.0047
848 RASH 2063 0.0047
849 DIZZINESS 2358 0.0047
850 VISUAL IMPAIRMENT 583 0.0047
851 CONJUNCTIVITIS 87 0.0047
852 COMPLICATION ASSOCIATED WITH DEVICE 68 0.0047
853 MENTAL IMPAIRMENT 113 0.0047
854 DIALYSIS 66 0.0046
855 SUICIDE ATTEMPT 281 0.0046
856 DIABETES MELLITUS INADEQUATE CONTROL 82 0.0046
857 DYSPHONIA 270 0.0046
858 HAEMORRHAGE 480 0.0046
859 TINNITUS 210 0.0046
860 TREATMENT NONCOMPLIANCE 250 0.0046
861 HOT FLUSH 343 0.0045
862 SENSORY DISTURBANCE 73 0.0045
863 SWELLING FACE 295 0.0045
864 IRRITABILITY 272 0.0045
865 HYPOAESTHESIA ORAL 68 0.0045
866 SUICIDAL IDEATION 412 0.0045
867 VERTIGO 273 0.0045
868 ADVERSE DRUG REACTION 401 0.0045
869 FEELING ABNORMAL 1067 0.0044
870 SKIN EXFOLIATION 374 0.0044
871 PHARYNGEAL OEDEMA 68 0.0044
872 ALOPECIA 868 0.0044
873 SWOLLEN TONGUE 138 0.0044
874 TRANSIENT ISCHAEMIC ATTACK 148 0.0044
875 FULL BLOOD COUNT DECREASED 88 0.0044
876 COLON CANCER 65 0.0044
877 CEREBROVASCULAR ACCIDENT 738 0.0044
878 DRUG EFFECT DECREASED 234 0.0043
879 ERYTHEMA 890 0.0043
880 OSTEONECROSIS 142 0.0043
881 THIRST 77 0.0043
882 FEMUR FRACTURE 133 0.0043
883 PALPITATIONS 499 0.0043
884 LUNG NEOPLASM MALIGNANT 175 0.0043
885 CARDIOVASCULAR DISORDER 107 0.0042
886 ABNORMAL DREAMS 116 0.0042
887 PRODUCT USE IN UNAPPROVED INDICATION 1036 0.0042
888 MYALGIA 708 0.0042
889 POLLAKIURIA 173 0.0041
890 EYE DISORDER 136 0.0041
891 PRURITUS 1586 0.0041
892 FRACTURE 78 0.0041
893 AGRANULOCYTOSIS 76 0.0041
894 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 105 0.0041
895 DYSTONIA 79 0.0041
896 MYOCARDIAL INFARCTION 702 0.0040
897 PRURITUS GENERALISED 87 0.0040
898 DRUG INEFFECTIVE 5295 0.0040
899 RASH PRURITIC 217 0.0040
900 PROTEINURIA 76 0.0040
901 DEPRESSED MOOD 209 0.0039
902 DRUG ADMINISTRATION ERROR 121 0.0039
903 PHOTOSENSITIVITY REACTION 65 0.0039
904 AGEUSIA 98 0.0039
905 DYSGEUSIA 287 0.0039
906 INTERSTITIAL LUNG DISEASE 187 0.0039
907 INTENTIONAL SELF-INJURY 77 0.0038
908 DEAFNESS 99 0.0038
909 RASH GENERALISED 98 0.0038
910 PHOTOPHOBIA 71 0.0038
911 ILLNESS 387 0.0038
912 CARDIAC DISORDER 350 0.0037
913 ISCHAEMIC STROKE 66 0.0037
914 DERMATITIS 77 0.0037
915 HEPATIC FUNCTION ABNORMAL 136 0.0036
916 VISION BLURRED 494 0.0036
917 THROAT TIGHTNESS 97 0.0036
918 LACRIMATION INCREASED 107 0.0035
919 NASAL CONGESTION 207 0.0035
920 CEREBRAL INFARCTION 86 0.0035
921 ADVERSE EVENT 323 0.0035
922 ERECTILE DYSFUNCTION 90 0.0035
923 EMOTIONAL DISORDER 107 0.0035
924 LIP SWELLING 115 0.0034
925 IMPAIRED WORK ABILITY 73 0.0034
926 UNDERDOSE 247 0.0034
927 NEEDLE ISSUE 98 0.0034
928 BLOOD GLUCOSE DECREASED 161 0.0033
929 FLUSHING 340 0.0033
930 MOOD ALTERED 91 0.0033
931 DRUG EXPOSURE DURING PREGNANCY 113 0.0033
932 PRODUCT PRESCRIBING ERROR 79 0.0033
933 PRODUCT ADMINISTRATION ERROR 67 0.0033
934 PANCREATIC CARCINOMA 95 0.0033
935 ANGER 111 0.0033
936 THROAT IRRITATION 147 0.0033
937 RASH MACULAR 114 0.0033
938 SURGERY 188 0.0032
939 MOOD SWINGS 102 0.0032
940 EYE SWELLING 119 0.0032
941 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 574 0.0032
942 RASH PAPULAR 69 0.0031
943 INCORRECT ROUTE OF DRUG ADMINISTRATION 110 0.0031
944 BLINDNESS 121 0.0030
945 COVID-19 509 0.0029
946 DEVICE DISLOCATION 125 0.0029
947 THERAPEUTIC RESPONSE UNEXPECTED 127 0.0028
948 VISUAL ACUITY REDUCED 94 0.0028
949 PRODUCT ADHESION ISSUE 100 0.0028
950 THERAPY CESSATION 143 0.0028
951 DRY EYE 138 0.0028
952 HOSPITALISATION 422 0.0027
953 DIABETIC KETOACIDOSIS 65 0.0027
954 EYE PAIN 152 0.0027
955 INCORRECT DRUG ADMINISTRATION DURATION 75 0.0027
956 DRUG EFFECT INCOMPLETE 96 0.0026
957 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 187 0.0026
958 HYPOACUSIS 111 0.0026
959 BLOOD GLUCOSE INCREASED 474 0.0025
960 DRUG DOSE OMISSION 414 0.0025
961 BONE DENSITY DECREASED 78 0.0025
962 OCULAR HYPERAEMIA 117 0.0025
963 PAIN OF SKIN 65 0.0024
964 INCORRECT DOSE ADMINISTERED 551 0.0024
965 MULTIPLE SCLEROSIS 112 0.0023
966 DEVICE MALFUNCTION 162 0.0023
967 THERAPEUTIC RESPONSE SHORTENED 76 0.0023
968 DISEASE RECURRENCE 109 0.0023
969 PRODUCT QUALITY ISSUE 299 0.0022
970 VAGINAL HAEMORRHAGE 95 0.0022
971 ECZEMA 114 0.0022
972 MULTIPLE SCLEROSIS RELAPSE 141 0.0021
973 INJECTION SITE MASS 72 0.0019
974 DEVICE BREAKAGE 77 0.0019
975 DRY SKIN 252 0.0019
976 DEVICE ISSUE 167 0.0019
977 PRODUCT DOSE OMISSION 121 0.0019
978 INJECTION SITE PAIN 542 0.0018
979 INJECTION SITE BRUISING 139 0.0017
980 PROSTATE CANCER 135 0.0017
981 THERAPY INTERRUPTED 114 0.0016
982 PRODUCT DOSE OMISSION ISSUE 456 0.0015
983 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 299 0.0015
984 INJECTION SITE HAEMORRHAGE 116 0.0015
985 SKIN BURNING SENSATION 96 0.0013
986 INJECTION SITE REACTION 88 0.0013
987 ACNE 95 0.0013
988 PRODUCT SUBSTITUTION ISSUE 72 0.0012
989 INJECTION SITE ERYTHEMA 152 0.0012
990 BREAST CANCER 108 0.0012
991 INJECTION SITE PRURITUS 69 0.0010
992 INJECTION SITE SWELLING 78 0.0010
993 ACCIDENTAL EXPOSURE TO PRODUCT 86 0.0008
994 NO ADVERSE EVENT 136 0.0007